{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:50:37Z","timestamp":1769694637668,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["1007001201003"],"award-info":[{"award-number":["1007001201003"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["2020-1\/12960"],"award-info":[{"award-number":["2020-1\/12960"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chemo-reirradiation has emerged as a feasible neoadjuvant therapy to improve resectability in locally recurrent rectal cancer (LRRC). However, its combination with surgery and intraoperative electron radiotherapy (IOERT) raises concerns regarding cumulative toxicity. This retrospective study aimed to evaluate acute and late toxicity profiles, local control and survival outcomes, following this multimodal approach in our institution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>LRRC patients who underwent chemo-reirradiation and surgery with IOERT (median cumulative tumour dose of 113\u00a0Gy, \u03b1\/\u03b2\u2009=\u200910\u00a0Gy) between September 2021 to December 2024 were retrospectively analysed. Acute and late treatment-related toxicities (CTCAE) were recorded in a prospectively maintained database. Secondary outcomes were overall survival (OS) and local re-recurrence-free survival (LRFS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 40 patients, no grade 4 or 5 toxicities were observed. Acute cumulative treatment-related grade 3 toxicities occurred in 14\/37 (38%) patients, predominantly consisting of erectile dysfunction (5\/37, 14%), abscess formation (4\/37, 11%) or peripheral neuropathy (2\/37, 5%). Late grade 3 toxicities occurred in 13\/30 (43%) patients, comprising mainly of erectile dysfunction (5\/30, 17%), renal disorders (5\/30, 17%) or peripheral neuropathy (2\/30, 7%). After a median follow-up period of 21 months (IQR 12\u201332) after surgery, 2-year overall survival (OS) and local re-recurrence-free survival (LRFS) were 75.7% and 37.2%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In previously irradiated LRRC patients, a multimodality approach combining chemo-reirradiation and extensive surgery with IOERT demonstrated acceptable treatment-related toxicities and favourable oncological outcomes for this high-risk population. Further research with longer follow-up is warranted to identify risk factors associated with treatment-related toxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-025-02782-w","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T15:34:40Z","timestamp":1766504080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neoadjuvant chemo-reirradiation followed by resection and intraoperative electron beam radiotherapy: outcomes of multimodality treatment for locally recurrent rectal cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"F. E. C.","family":"Vande Kerckhove","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Piqeur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Banken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. C.","family":"Morsink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. C.","family":"Rijkaart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S.","family":"Cnossen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. H. N.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. C. A.","family":"Huibregtse Bimmel-Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. E. G.","family":"van Hellemond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nederend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. J. T.","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. G.","family":"Bloemen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. W. A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Verrijssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. M. U.","family":"Peulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"issue":"11","key":"2782_CR1","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.ejso.2019.06.016","volume":"45","author":"R Detering","year":"2019","unstructured":"Detering R, Karthaus EG, Borstlap WAA, van de Marijnen CAM, Bemelman WA, et al. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial. Eur J Surg Oncol. 2019;45(11):2059\u201369.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"2782_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","volume":"12","author":"W van Gijn","year":"2011","unstructured":"van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575\u201382.","journal-title":"Lancet Oncol"},{"issue":"12","key":"2782_CR3","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.21037\/atm-21-2298","volume":"9","author":"Z Gao","year":"2021","unstructured":"Gao Z, Gu J. Surgical treatment of locally recurrent rectal cancer: a narrative review. Ann Transl Med. 2021;9(12):1026.","journal-title":"Ann Transl Med"},{"issue":"2","key":"2782_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1503\/cjs.025911","volume":"56","author":"PJ Tanis","year":"2013","unstructured":"Tanis PJ, Doeksen A, van Lanschot JJ. Intentionally curative treatment of locally recurrent rectal cancer: a systematic review. Can J Surg. 2013;56(2):135\u201344.","journal-title":"Can J Surg"},{"issue":"5","key":"2782_CR5","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","volume":"22","author":"T Conroy","year":"2021","unstructured":"Conroy T, Bosset JF, Etienne PL, Rio E, Francois E, Mesgouez-Nebout N, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(5):702\u201315.","journal-title":"Lancet Oncol"},{"key":"2782_CR6","doi-asserted-by":"publisher","first-page":"102177","DOI":"10.1016\/j.ctrv.2021.102177","volume":"96","author":"EF Giunta","year":"2021","unstructured":"Giunta EF, Bregni G, Pretta A, Deleporte A, Liberale G, Bali AM, et al. Total neoadjuvant therapy for rectal cancer: making sense of the results from the RAPIDO and PRODIGE 23 trials. Cancer Treat Rev. 2021;96:102177.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"2782_CR7","doi-asserted-by":"publisher","first-page":"e215445","DOI":"10.1001\/jamaoncol.2021.5445","volume":"8","author":"E Fokas","year":"2022","unstructured":"Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R, et al. Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: Long-term results of the CAO\/ARO\/AIO-12 randomized clinical trial. JAMA Oncol. 2022;8(1):e215445.","journal-title":"JAMA Oncol"},{"issue":"3","key":"2782_CR8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ejso.2019.10.037","volume":"46","author":"JAW Hagemans","year":"2020","unstructured":"Hagemans JAW, van Rees JM, Alberda WJ, Rothbarth J, Nuyttens J, van Meerten E, et al. Locally recurrent rectal cancer; long-term outcome of curative surgical and non-surgical treatment of 447 consecutive patients in a tertiary referral centre. Eur J Surg Oncol. 2020;46(3):448\u201354.","journal-title":"Eur J Surg Oncol"},{"key":"2782_CR9","doi-asserted-by":"crossref","unstructured":"PelvEx C. Contemporary management of locally advanced and recurrent rectal cancer: views from the PelvEx collaborative. Cancers (Basel). 2022;14(5).","DOI":"10.3390\/cancers14051161"},{"issue":"1","key":"2782_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13014-021-01974-4","volume":"17","author":"H Wu","year":"2022","unstructured":"Wu H, Fan C, Fang C, Huang L, Li Y, Zhou Z. Preoperative short-course radiotherapy followed by consolidation chemotherapy for treatment with locally advanced rectal cancer: a meta-analysis. Radiat Oncol. 2022;17(1):14.","journal-title":"Radiat Oncol"},{"issue":"7","key":"2782_CR11","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1245\/s10434-008-9896-z","volume":"15","author":"RC Dresen","year":"2008","unstructured":"Dresen RC, Gosens MJ, Martijn H, Nieuwenhuijzen GA, Creemers GJ, Daniels-Gooszen AW, et al. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol. 2008;15(7):1937\u201347.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2782_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijrobp.2009.10.046","volume":"79","author":"MG Haddock","year":"2011","unstructured":"Haddock MG, Miller RC, Nelson H, Pemberton JH, Dozois EJ, Alberts SR, Gunderson LL. Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer. Int J Radiat Oncol Biol Phys. 2011;79(1):143\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2782_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejso.2016.08.015","volume":"43","author":"FA Holman","year":"2017","unstructured":"Holman FA, Bosman SJ, Haddock MG, Gunderson LL, Kusters M, Nieuwenhuijzen GA, et al. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: results of 565 patients of two major treatment centres. Eur J Surg Oncol. 2017;43(1):107\u201317.","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"2782_CR14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/j.1463-1318.2012.03005.x","volume":"14","author":"A Bhangu","year":"2012","unstructured":"Bhangu A, Ali SM, Darzi A, Brown G, Tekkis P. Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer. Colorectal Dis. 2012;14(12):1457\u201366.","journal-title":"Colorectal Dis"},{"key":"2782_CR15","doi-asserted-by":"publisher","first-page":"102736","DOI":"10.1016\/j.ctrv.2024.102736","volume":"127","author":"F Piqeur","year":"2024","unstructured":"Piqeur F, Creemers DMJ, Banken E, Coolen L, Tanis PJ, Maas M, et al. Dutch National guidelines for locally recurrent rectal cancer. Cancer Treat Rev. 2024;127:102736.","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"2782_CR16","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","volume":"23","author":"N Andratschke","year":"2022","unstructured":"Andratschke N, Willmann J, Appelt AL, Alyamani N, Balermpas P, Baumert BG, et al. European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus on re-irradiation: definition, reporting, and clinical decision making. Lancet Oncol. 2022;23(10):e469\u201378.","journal-title":"Lancet Oncol"},{"issue":"3","key":"2782_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0360-3016(97)00340-4","volume":"39","author":"M Mohiuddin","year":"1997","unstructured":"Mohiuddin M, Marks GM, Lingareddy V, Marks J. Curative surgical resection following reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 1997;39(3):643\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2782_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1463-1318.2003.00501.x","volume":"5","author":"B Glimelius","year":"2003","unstructured":"Glimelius B. Recurrent rectal cancer. The pre-irradiated primary tumour: can more radiotherapy be given? Colorectal Dis. 2003;5(5):501\u20133.","journal-title":"Colorectal Dis"},{"issue":"4","key":"2782_CR19","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.ijrobp.2005.09.017","volume":"64","author":"V Valentini","year":"2006","unstructured":"Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Int J Radiat Oncol Biol Phys. 2006;64(4):1129\u201339.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"2782_CR20","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1245\/s10434-021-10070-6","volume":"28","author":"EA Dijkstra","year":"2021","unstructured":"Dijkstra EA, Mul VEM, Hemmer PHJ, Havenga K, Hospers GAP, Muijs CT, van Etten B. Re-Irradiation in patients with recurrent rectal cancer is safe and feasible. Ann Surg Oncol. 2021;28(9):5194\u2013204.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2782_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.radonc.2016.12.015","volume":"122","author":"R Tao","year":"2017","unstructured":"Tao R, Tsai CJ, Jensen G, Eng C, Kopetz S, Overman MJ, et al. Hyperfractionated accelerated reirradiation for rectal cancer: an analysis of outcomes and toxicity. Radiother Oncol. 2017;122(1):146\u201351.","journal-title":"Radiother Oncol"},{"key":"2782_CR22","doi-asserted-by":"publisher","first-page":"102419","DOI":"10.1016\/j.ctrv.2022.102419","volume":"109","author":"MG Fadel","year":"2022","unstructured":"Fadel MG, Ahmed M, Malietzis G, Pellino G, Rasheed S, Brown G, et al. Oncological outcomes of multimodality treatment for patients undergoing surgery for locally recurrent rectal cancer: A systematic review. Cancer Treat Rev. 2022;109:102419.","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"2782_CR23","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/bjs.9569","volume":"101","author":"SJ Bosman","year":"2014","unstructured":"Bosman SJ, Holman FA, Nieuwenhuijzen GA, Martijn H, Creemers GJ, Rutten HJ. Feasibility of reirradiation in the treatment of locally recurrent rectal cancer. Br J Surg. 2014;101(10):1280\u20139.","journal-title":"Br J Surg"},{"issue":"3","key":"2782_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.radonc.2008.02.021","volume":"87","author":"M Vermaas","year":"2008","unstructured":"Vermaas M, Nuyttens JJ, Ferenschild FT, Verhoef C, Eggermont AM, de Wilt JH. Reirradiation, surgery and IORT for recurrent rectal cancer in previously irradiated patients. Radiother Oncol. 2008;87(3):357\u201360.","journal-title":"Radiother Oncol"},{"issue":"5","key":"2782_CR25","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/cncr.10799","volume":"95","author":"M Mohiuddin","year":"2002","unstructured":"Mohiuddin M, Marks G, Marks J. Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer. 2002;95(5):1144\u201350.","journal-title":"Cancer"},{"issue":"1","key":"2782_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13014-016-0752-1","volume":"12","author":"MG Haddock","year":"2017","unstructured":"Haddock MG. Intraoperative radiation therapy for colon and rectal cancers: a clinical review. Radiat Oncol. 2017;12(1):11.","journal-title":"Radiat Oncol"},{"issue":"12","key":"2782_CR27","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/BF02234450","volume":"44","author":"GH Mannaerts","year":"2001","unstructured":"Mannaerts GH, Rutten HJ, Martijn H, Hanssens PE, Wiggers T. Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer. Dis Colon Rectum. 2001;44(12):1749\u201358.","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"2782_CR28","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/01.SLA.0000059972.90598.5F","volume":"237","author":"D Hahnloser","year":"2003","unstructured":"Hahnloser D, Nelson H, Gunderson LL, Hassan I, Haddock MG, O\u2019Connell MJ, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg. 2003;237(4):502\u20138.","journal-title":"Ann Surg"},{"issue":"Suppl A","key":"2782_CR29","first-page":"S16","volume":"26","author":"HJ Rutten","year":"2000","unstructured":"Rutten HJ, Mannaerts GH, Martijn H, Wiggers T. Intraoperative radiotherapy for locally recurrent rectal cancer in the Netherlands. Eur J Surg Oncol. 2000;26(Suppl A):S16\u201320.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"2782_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5114\/jcb.2024.139276","volume":"16","author":"F Piqeur","year":"2024","unstructured":"Piqeur F, Peulen HMU, Cnossen JS, Bimmel-Nagel C, Rutten HJT, Burger JWA, Verrijssen AE. Post-operative complications following dose adaptation of intra-operative electron beam radiation therapy in locally advanced or recurrent rectal cancer. J Contemp Brachytherapy. 2024;16(2):85\u201394.","journal-title":"J Contemp Brachytherapy"},{"issue":"4","key":"2782_CR31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.5114\/jcb.2022.118305","volume":"14","author":"AE Verrijssen","year":"2022","unstructured":"Verrijssen AE, Dries WJF, Cnossen JS, Theuws J, van den Peulen HMU, et al. Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer. J Contemp Brachytherapy. 2022;14(4):370\u20138.","journal-title":"J Contemp Brachytherapy"},{"key":"2782_CR32","unstructured":"Dutch National Guidelines for Neoadjuvant Therapy of Locally Advanced Rectal Cancer. In. Richtlijnendatabase, editor: Federation of Medical Specialists; 2022."},{"key":"2782_CR33","unstructured":"Dutch National Guidelines for Colorectal Cancer. In. Specialists FoM, editor.: Richtlijnendatabase; 2025."},{"key":"2782_CR34","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). Version 5.0. US Department of Health and Human Services; 2017."},{"issue":"2","key":"2782_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg"},{"key":"2782_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.radonc.2019.05.021","volume":"140","author":"J Lee","year":"2019","unstructured":"Lee J, Kim CY, Koom WS, Rim CH. Practical effectiveness of re-irradiation with or without surgery for locoregional recurrence of rectal cancer: A meta-analysis and systematic review. Radiother Oncol. 2019;140:10\u20139.","journal-title":"Radiother Oncol"},{"issue":"3","key":"2782_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.semradonc.2016.02.004","volume":"26","author":"MG Haddock","year":"2016","unstructured":"Haddock MG. Irradiation of very locally advanced and recurrent rectal cancer. Semin Radiat Oncol. 2016;26(3):226\u201335.","journal-title":"Semin Radiat Oncol"},{"issue":"5","key":"2782_CR38","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0360-3016(00)01528-5","volume":"49","author":"MG Haddock","year":"2001","unstructured":"Haddock MG, Gunderson LL, Nelson H, Cha SS, Devine RM, Dozois RR, Wolff BG. Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients. Int J Radiat Oncol Biol Phys. 2001;49(5):1267\u201374.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2782_CR39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109\u201322.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2782_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.radonc.2011.03.010","volume":"99","author":"H Abusaris","year":"2011","unstructured":"Abusaris H, Storchi PR, Brandwijk RP, Nuyttens JJ. Second re-irradiation: efficacy, dose and toxicity in patients who received three courses of radiotherapy with overlapping fields. Radiother Oncol. 2011;99(2):235\u20139.","journal-title":"Radiother Oncol"},{"issue":"4","key":"2782_CR41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/jso.25351","volume":"119","author":"J Nijkamp","year":"2019","unstructured":"Nijkamp J, Kuhlmann KFD, Ivashchenko O, Pouw B, Hoetjes N, Lindenberg MA, et al. Prospective study on image-guided navigation surgery for pelvic malignancies. J Surg Oncol. 2019;119(4):510\u20137.","journal-title":"J Surg Oncol"},{"issue":"7","key":"2782_CR42","doi-asserted-by":"publisher","first-page":"e208522","DOI":"10.1001\/jamanetworkopen.2020.8522","volume":"3","author":"END Kok","year":"2020","unstructured":"Kok END, van Veen R, Groen HC, Heerink WJ, Hoetjes NJ, van Werkhoven E, et al. Association of Image-Guided navigation with complete resection rate in patients with locally advanced primary and recurrent rectal cancer: A nonrandomized controlled trial. JAMA Netw Open. 2020;3(7):e208522.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2782_CR43","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11548-024-03299-5","volume":"20","author":"MAJ Hiep","year":"2025","unstructured":"Hiep MAJ, Heerink WJ, Groen HC, Saiz LA, Grotenhuis BA, Beets GL, et al. Real-time intraoperative ultrasound registration for accurate surgical navigation in patients with pelvic malignancies. Int J Comput Assist Radiol Surg. 2025;20(2):249\u201358.","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"2782_CR44","unstructured":"Assessment of intraoperative radiotherapy in locally advanced or locally recurrent rectal cancer using image-guided navigation, QUART study. Dutch National Trial Registry; 2024."},{"issue":"3","key":"2782_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/jrr\/rrae019","volume":"65","author":"Y Takagawa","year":"2024","unstructured":"Takagawa Y, Suzuki M, Seto I, Azami Y, Machida M, Takayama K, et al. Proton beam reirradiation for locally recurrent rectal cancer patients with prior pelvic irradiation. J Radiat Res. 2024;65(3):379\u201386.","journal-title":"J Radiat Res"},{"issue":"3","key":"2782_CR46","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.21873\/invivo.11944","volume":"34","author":"A Barcellini","year":"2020","unstructured":"Barcellini A, Vitolo V, Cobianchi L, Peloso A, Vanoli A, Mirandola A, et al. Re-irradiation with carbon ion radiotherapy for pelvic rectal cancer recurrences in patients previously irradiated to the pelvis. Vivo. 2020;34(3):1547\u201353.","journal-title":"Vivo"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02782-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02782-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02782-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T03:04:18Z","timestamp":1769655858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-025-02782-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2782"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02782-w","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Medical Research Ethics Committees United \u2013 Nieuwegein (registration number AW25.011\/W22.236). The study was not subject to the Medical Research Involving Human Subjects Act and written informed consent for participation was waived for this study in accordance with the national legislation and the institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}